We are launching a series of publications exploring how artificial intelligence could transform healthcare in the coming years and decades. Our goal is not to offer ready-made reforms or blueprints for the future, but to examine possible scenarios for the industry's evolution.

We will explore what medicine might look like tomorrow, which technologies will become part of everyday practice, how patients and physicians will experience these changes, and what new conflicts, risks, and tensions will inevitably emerge along the way.

We are interested not only in technological advances but also in the fundamental shift in how we approach human health: what will take center stage, how medical decisions will be made, and what role data, prevention, and personalized health management will play.

Through this series, we aim to look beyond the horizon to understand what the next phase of healthcare evolution might look like.

Technological Shift.

Medicine is transitioning from a system of diagnosis to a system of continuous measurement and prediction of human state. This is a shift in which the diagnosis ceases to be the central focal point. What becomes central is the trajectory of the body's health parameters over time — its continuous variability, not the isolated episode of disease detection.

Defining the term. I call this new reality AI-continuous trajectory-based preventive medicine. At its core is not simply the use of artificial intelligence, but a fundamental shift in logic: the object of observation becomes not the disease as an event, but the trajectory of a person's physiological state over continuous time. AI here is not an ornament or a diagnostic tool — it is the engine that makes it possible to see, analyze, and predict that trajectory. Without it, the continuous stream of data remains just noise.

The terms Wellness Medicine and Preventive Medicin* do not fully capture the key characteristics of this approach. In particular, they lack emphasis on continuity and non-invasiveness — fundamental qualities that deserve to be part of the definition. For simplicity, let's refer to it as **AI Preventive Medicine**, but understand that it is characterized by: (a) continuous monitoring of physiological parameters, (b) computation of risks and assessments, and the generation of recommendations, and (c) a focus on trajectories of change and the limits of parameter values.

The Problem with Symptom-Based Medicine.

Today's medicine remains largely symptom-driven. A person sees a doctor only when something hurts, causes concern, or interferes with daily life. Only then does diagnosis, testing, and treatment begin.

But the fundamental problem is that most serious diseases develop long before any noticeable symptoms appear. This period — sometimes years or even decades — remains invisible to both the patient and the healthcare system.

Type 2 diabetes can develop over 5–10 years before diagnosis. During this time, insulin resistance gradually builds, glucose metabolism deteriorates, and blood vessels, kidneys, and the nervous system become damaged. The person often feels nothing critical and continues living with a sense of normalcy.

Myocardial infarction rarely occurs out of the blue. It is preceded by years of atherosclerosis progression, chronic inflammation of the vascular wall, changes in blood properties, and gradually worsening blood supply to the heart.

Stroke also does not appear "out of nowhere." Cerebrovascular disturbances, chronic hypoxia, and vascular changes can accumulate over years.

Chronic kidney disease develops gradually and often asymptomatically, leading to significant loss of organ function before it is ever detected.

Liver diseases — including non-alcoholic fatty liver disease, fibrosis, and cirrhosis — also develop slowly and are often discovered incidentally.

Mental health follows a similar pattern: depression, anxiety disorders, and chronic stress accumulate imperceptibly, and the person gradually adapts to a worsening state.

Oncological diseases illustrate the importance of time most clearly. In early stages, many cancers may produce no symptoms at all, yet the timing of detection often determines the outcome of treatment.

Today's healthcare system is built not only around diagnosis but also around an institutional monopoly on interpretation.

Only a physician has the authority to turn data into medical reality. Even if a person observes changes in their own body on a daily basis, those observations do not acquire medical status without a professional conclusion.

This creates a fundamental asymmetry: a person can sense and record changes but cannot legitimize them.

Artificial intelligence does not simply supplement this system. It dismantles its monopolistic structure of interpretation.

It creates a continuous layer of analysis that operates outside of clinical visits and episodes of care. When the system can analyze millions of parameters in real time, the physician ceases to be the sole source of medical interpretation. The physician becomes a participant in the system, but no longer its sole arbitrator.

This marks a transition from a monopoly on knowledge to a distributed interpretation of a person's state.

Importantly, these two systems do not merely complement each other. They represent different modes of seeing the same body. In AI-trajectory medicine, the episodic visit to the doctor ceases to be the main event. The main event becomes the continuous line.

The more data and the more sensitive the analytics, the higher the likelihood of detecting risk signals — even in the absence of symptoms.

This creates what we might call "disease from measurement": the person feels fine, but the system detects deviations. A new reality emerges — a conflict between subjective experience and the algorithmic model of health. AI-continuous medicine does not eliminate this conflict, but it makes it visible.

One of the key effects of AI-continuous medicine is the asymmetry of detection — a situation in which the system begins to identify and interpret physiological parameters that have not yet entered routine clinical observation.

Consider this scenario.

A person feels healthy. Standard lab results are within normal ranges. There is no diagnosis.

Yet a continuous monitoring system, processing pulse wave signals and related physiological parameters, detects changes: microcirculation becomes less efficient, vascular resistance increases, signs of insulin resistance appear, tissue oxygen consumption changes, blood viscosity rises, and metabolic stability declines.

Each individual indicator does not yet constitute disease.

But their dynamics begin to form a persistent pattern.

And this pattern appears before symptoms. Before diagnosis. Before clinical verification.

Example: Glucose at 5.3 mmol/L — a clinical norm. But the AI-continuous system Accofrisk AI sees that over the past three weeks, glucose has been steadily rising after each meal, HOMA-IR has increased from 1.8 to 2.4, and cerebral blood flow (CBF) has dropped by 7%. None of these parameters alone indicates a diagnosis. But their trajectory — that is the pattern of prediabetes and early cerebral hypoxia. One year before symptoms. Three years before diagnosis.

An asymmetry of detection emerges.

Clinical medicine says: insufficient evidence for diagnosis.

The AI-continuous system says: physiological changes are already underway.

The conflict here is not about error. It is about differing logics of observation.

Classical medicine works with episodic measurements and diagnostic thresholds. AI-continuous medicine works with continuous signals and early deviations from trajectory.

Therefore, the object of attention shifts. From diagnosis to process. From state to the movement of state.

The AI Flag-Based Health Monitoring System (AI-FHMS) operates on a simple principle: the initiative comes not from the patient but from the system. This is the reverse of the traditional model, where the individual decides when to see a doctor.

In the classical model, the patient arrives with symptoms. In the AI-FHMS, artificial intelligence continuously analyzes physiological data, and when the trajectory deviates from the norm, it raises a flag. This is not just a signal — it is an invitation to a checkup with a specific date and time, a preview of the suspected issue, a set of pre-visit recommendations, and a status of urgency.

The color of the flag determines the level of danger and the required action.

The track is clear. The person feels well, and all indicators are within their individual norm. No intervention is required; monitoring continues in standard mode.

Danger on the track. The system detects sustained deviations that are not yet disease but are already forming a risk pattern. The person receives an invitation for a checkup within the coming weeks, along with a preview of the issue and pre-visit recommendations. This is not panic, but attention is required.

The race is stopped. The system detects critical changes requiring immediate intervention. The person receives an invitation for an urgent visit within 48 hours, with a full preview of the problem, a danger status, and a clear action plan.

Mandatory pit stop. This flag sends the car into the pits. In medicine, this means the condition requires immediate diagnosis and correction. The system doesn't just recommend — it initiates a visit with the highest priority. The person must stop and undergo a full evaluation.

Warning of a faster car behind. In healthcare, this signals that the risk for this individual is higher than for others, and they need to give way to resources — receiving priority access to diagnostics or a specialist.

Disqualification. In medical logic, this means the patient has systematically ignored invitations and recommendations. The system records this as a conscious refusal to manage their health. The person is removed from the continuous monitoring program or transferred to a different level of responsibility.

The person receives a complete action plan. There is no need to guess which doctor to see or about what. Everything is already determined: the date, the problem, the pre-visit actions, and the degree of urgency. This changes patient behavior. They are no longer the initiator seeking help. They become a participant in a process driven by data. Their role is to respond to flags and follow recommendations.

AI-FHMS does not eliminate the physician. It changes their role. Instead of waiting for a patient with a problem, the physician receives a prepared case: data, a preview of the issue, and preliminary recommendations. All that remains is to confirm, clarify, or adjust. This makes their work more meaningful and less reactive.

The linear trust model is breaking down.

Instead of the "patient — physician — diagnosis" schema, a triangle emerges: patient — physician — artificial intelligence.

The key conflict of the future is not between humans and the system, but among three different modes of interpreting the same condition simultaneously. AI-continuous medicine makes this conflict explicit and constant.

The concept of normality is no longer fixed.

Instead of population averages, an individual dynamic norm emerges, based on the trajectory of the specific person.

Norm transforms from a boundary into a personal line of physiological state. This is one of the most important distinctions of AI-continuous medicine: normality becomes dynamic and personal.

Example: Two people with the same glucose level of 5.3 mmol/L may have opposite trajectories. For one, this is a peak; for the other, it is the lowest point. The population norm sees no difference. The individual trajectory does.

Myocardial blood perfusion means the actual blood
volume which perfuses through cardiac coronary artery
into myocardium within unit time.

At an excessive exercise, myocardial blood perfusion can
increase for a short time.

1. Under normal conditions, this index can fluctuate in a
certain degree for a short time. Suggestions: Continue the
dynamic monitoring.
2. Suggestions: Take a diet of low salt/fat in ordinary
time; more take fresh melons, fruits and vegetables; avoid
a tiredness; take a rational exercise; and visit a hospital in
time when necessary.

When the system shows risks in advance, a new ethical zone emerges.

The individual receives information about potential scenarios long before symptoms arise.

Questions arise not only about what counts as risk, but also about who bears responsibility for acting under conditions of probability.

But there is also the other side of this shift — the right not to know. AI-continuous medicine offers continuous prediction. Not everyone wants to learn 10 years before a heart attack that it will happen with 74% probability. This knowledge itself can become a disease — a hyperdiagnosis of existence, anxiety without an object. The individual has the right to live without looking at their risk profile every day. The problem is that insurance companies and employers may deny them that right. Knowledge becomes mandatory. The right not to know is a luxury that the economics of risk eliminates.

When health becomes continuously measurable, it inevitably becomes an economically valued parameter as well.

A health risk score emerges — a dynamic assessment of a person's condition.

Insurance shifts from the fact of illness to the probability of an event.

The individual is no longer simply "healthy or sick" — they become a continuously recalculated risk profile.

Employers and insurance systems begin to account not for diagnosis, but for projected resilience.

Thus, health becomes an economic variable that affects access to resources.

A new type of inequality emerges — not based on the fact of illness, but on the assessed probability of illness.

But this inequality runs deeper. There will emerge not just a health risk score, but an "algorithmic class." People with "good" trajectories will receive cheaper insurance, access to credit, and better working conditions. People with "poor" risks — even if clinically healthy — will find themselves in a zone of economic disqualification. And this will not be discrimination based on illness, but discrimination based on prediction. Legal. Automatic. Continuous. AI does not create this inequality, but it makes it technically possible — and invisible to the legal system.

Moreover, AI does not see contracts. It does not know that modern medicine profits from illness, not health. If algorithms truly learn to predict and prevent disease at the preclinical stage — the economic model of pharma, insurance, and hospitals built on treatment would collapse. A conflict arises: the algorithm says "treat one year before symptoms," and the system responds "no diagnosis — no funding." AI-continuous medicine hits not a technological wall, but a contractual one. And this is the hardest part to rewrite. AI is powerless here.

The New Architecture of Medicine.

A three-layer system is forming.

Continuous measurements of the body: physiology, metabolism, behavior, stress, nutrition, physical load.

Artificial intelligence transforms the data stream into risk profiles and scenarios for the progression of the condition.

The physician, the system, or the individual themselves take action: prevention, checkups, correction, treatment.

In AI-continuous medicine, these three layers operate continuously and simultaneously — not episodically.

It is impossible to build a continuous trajectory if every measurement requires a needle, a test tube, or a visit to the lab.

Only when a wrist-worn sensor can measure glucose, lactate, blood viscosity, and cerebral blood flow without piercing the skin — only then does health truly become a continuous data stream.

Non-invasiveness is not convenience. It is an epistemological condition.

Medicine is no longer a system of episodic decisions.

It becomes a continuous data stream about the individual.

And within this system, the central question changes.

Not "what hurts?"

Not even "what is your diagnosis?"

But — what is happening to you right now, in the trajectory of your state?

And the following questions become inevitable.

Who has the right to interpret it?

But there is an even deeper question: what do we do with this interpretation, here and now?

AI-continuous trajectory medicine does not end with a diagnosis. It ends with action — a personalized recommendation that emerges from the trajectory. Slow down. Change your breathing. Check your neck. Drink some water. See a doctor. This is not prediction for its own sake. It is prediction embedded in life.

And the final question — the most difficult one — is: who owns my continuous state data? Me? My physician? The Accofrisk AI? The state?

Until we answer the question of ownership over prediction, any AI-continuous medicine will serve whoever owns the interpretation. And ownership of interpretation is ownership of the individual's future.

Keep reading our blog